Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective - Corporate Finance and Governance - Heiko Schoen - Books - Peter Lang AG - 9783631663813 - September 28, 2015
In case cover and title do not match, the title is correct

Heiko Schoen
Pharma M&A versus alliances and its underlying value drivers: Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective - Corporate Finance and Governance New edition

Price
$ 70.99
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 7 - 13

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

201 pages

Media Books     Hardcover Book   (Book with hard spine and cover)
Released September 28, 2015
ISBN13 9783631663813
Publishers Peter Lang AG
Pages 201
Dimensions 215 × 154 × 17 mm   ·   362 g
Language French  

Mere med samme udgiver

See all of Heiko Schoen ( e.g. Hardcover Book )